The IPO size is likely to be in the range of $500-600 million and will comprise a large share of secondary share sales by existing investors.
Bain Capital, KKR and TPG Capital are also in the fray to pick up a stake in the coffee chain.
Torrent Pharma has teamed with private-equity firm Apax Partners to emerge as the frontrunner to buy Hyderabad-based Gland Pharma, sources have told CNBC-TV18.
Cheering up the deal, experts feel that the deal is positive. Moshe Katri, MD, Cowen & Co, Rohit Kumar Anand of PINC Research and Sandip Agarwal, IT Analyst at Antique Stock Broking gave their perspective.